Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CODEXIS, INC. | 143,583 | reported | 10 Jun 2025 | tx 4+143,583 |
| SANGAMO THERAPEUTICS, INC | 112,600 | reported | 12 Jun 2025 | tx 26+378,250−50,000 |
| Armata Pharmaceuticals, Inc. | 27,383 | reported | 22 May 2019 | tx 9+375,383 |
| ACHIEVE LIFE SCIENCES, INC. | 22,000 | reported | 12 May 2020 | tx 26+135,461−9,500 |
| IMPEL NEUROPHARMA INC | 12,789 | reported | 16 Jun 2022 | tx 17+105,432−388,685 |
| NEOSE TECHNOLOGIES INC | 0 | reported | 27 Jan 2009 | tx 4+22,869−2,869 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 25,000 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 50,000 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | CODEXIS, INC. | 40,983 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | CODEXIS, INC. | 30,120 | 0.00 USD | |
| 04 Jun 2024 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 25,000 | 0.00 USD | |
| 04 Jun 2024 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 50,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | CODEXIS, INC. | 34,602 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 13,900 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 27,750 | 0.00 USD | deriv |
| 16 Dec 2022 | GRANT_AWARD | CODEXIS, INC. | 37,878 | 0.00 USD | |
| 16 Jun 2022 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 12,789 | 0.00 USD | deriv |
| 01 Jun 2022 | PURCHASE | SANGAMO THERAPEUTICS, INC | 5,000 | 3.60 USD | first after silence |
| 25 Feb 2022 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 12,500 | 0.00 USD | |
| 25 Feb 2022 | GRANT_AWARD | SANGAMO THERAPEUTICS, INC | 25,000 | 0.00 USD | deriv |
| 11 Jul 2021 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 11,500 | 0.00 USD | deriv |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 3,732 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 7,355 | — | |
| 27 Apr 2021 | OTHER | IMPEL NEUROPHARMA INC | 458 | 0.00 USD | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 8,793 | — | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 271 | 13.50 USD | |
| 27 Apr 2021 | OTHER | IMPEL NEUROPHARMA INC | 1,666 | 0.00 USD | |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 61,109 | 0.00 USD | deriv |
| 27 Apr 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 13,756 | 8.19 USD | deriv |
| 27 Apr 2021 | EXERCISE | IMPEL NEUROPHARMA INC | 13,756 | 0.00 USD | deriv |
| 27 Apr 2021 | CONVERSION | IMPEL NEUROPHARMA INC | 120,447 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 01 Jun 2022.